Atherogenic dyslipidemia: cardiovascular risk and dietary intervention.
Atherogenic dyslipidemia comprises a triad of increased blood concentrations of small, dense low-density lipoprotein (LDL) particles, decreased high-density lipoprotein (HDL) particles, and increased triglycerides. A typical feature of obesity, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus, atherogenic dyslipidemia has emerged as an important risk factor for myocardial infarction and cardiovascular disease. A number of genes have now been linked to this pattern of lipoprotein changes. Low-carbohydrate diets appear to have beneficial lipoprotein effects in individuals with atherogenic dyslipidemia, compared to high-carbohydrate diets, whereas the content of total fat or saturated fat in the diet appears to have little effect. Achieving a better understanding of the genetic and dietary influences underlying atherogenic dyslipidemia may provide clues to improved interventions to reduce the risk of cardiovascular disease in high-risk individuals.
Cardiology Division, Cardiovascular Research Center and Center for Human Genetic Research, Massachusetts General Hospital, CPZN 5th floor, Boston, MA 02114, USA. kmusunuru@partners.org
Kiran
K
Musunuru
D050197:Atherosclerosis / Q000178:diet therapy* / Q000235:genetics* / Q000378:metabolism / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000178:diet therapy* / Q000235:genetics* / Q000378:metabolism / Q000517:prevention & control; D004032:Diet; D004041:Dietary Fats / Q000009:adverse effects; D050171:Dyslipidemias / Q000178:diet therapy* / Q000235:genetics* / Q000378:metabolism / Q000517:prevention & control; D006801:Humans; D012307:Risk Factors
D004041:Dietary Fats